Roger Olofsson Bagge, MD, PhD, Gothenburg University, Gothenburg, Sweden, comments on key take-home messages from the Functional Assessment of Cancer Therapy Melanoma (FACT-M) questionnaire, which aimed to measure the physical and mental wellbeing of patients with melanoma. Dr Bagge emphasizes the need to standardize the measurement of quality of life in patients, which are often secondary endpoints. This interview took place at the American Society of Clinical Oncology (ASCO) 2022 Annual Meeting in Chicago, IL.